美通社

2024-05-07 22:10

Seragon Completes Pre-Clinical Study of Aging Intervention Candidate SRN-901

IRVINE, Calif., May 7, 2024 /PRNewswire/ -- Seragon Biosciences, Inc. today announced the completion of a pre-clinical study on its novel anti-aging candidate, SRN-901. This pivotal study, conducted in mice, was undertaken to evaluate the impact of SRN-901 on aging as well as various health markers.

Results from the study show that SRN-901 achieved one of the largest extensions of lifespan and healthspan to date in the treated population. Whole-genome transcriptome sequencing was performed on over 300 mice to assess the effects of SRN-901 at a molecular level. The results highlighted a significant increase in the expression of many genes associated with longevity and a notable reduction in the expression of genes linked to aging. Additionally, a metabolic panel revealed beneficial changes in several biomarkers associated with younger biological age.

Other tests were conducted to evaluate the effect of SRN-901 on healthspan, a measure of how long health is maintained over the course of one's life. The study also evaluated physical and cognitive function. Treadmill tests showed significantly enhanced endurance in elderly mice. Frailty scores showed marked improvement in the elderly mice receiving SRN-901, and there was a significant reduction in tumor occurrence in the treated group.

The research team at Seragon Biosciences is encouraged by the study's results and will conduct further analysis to uncover additional findings. These results will be published once the supplementary analysis is complete.

About Seragon Biosciences

Seragon Biosciences, Inc., headquartered in Irvine, California, is a research-based biopharmaceutical company dedicated to improving human and animal health through innovative science. Seragon Biosciences is committed to applying cutting-edge scientific and technological advancements to the fields of aging, metabolism, gene therapy, and bioinformatics. From the research end to consumer products and clinical applications, Seragon strives to bring people access to the most significant breakthroughs in medicine. For more information, please visit www.seragon.com.

source: Seragon Biosciences

WoW WoW星期三:健康網購產品低至$75 (只限今天)► 火速行動

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

靈媒與通靈有什麼差別?靈靈法同你解構扶乩、標童、碟仙!

日圓再創新低,即上etnet睇邊間銀行唱Yen最抵

etnet賞意大利葡萄汽酒乙支 (名額40個)

大國博弈

貨幣攻略

說說心理話

Watche Trends 2024

北上食買玩

Art Month 2024

理財秘笈

關注四高危機!

夏天養生食療

消委會報告

山今養生智慧